Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
China is the largest consumption place, with a consumption market share nearly 53.9% in 2017. Following China, North America is the second largest consumption place with the consumption market share of 20% in 2017.
Market competition is intense. CSL, Grifols, Shire (Baxalta), Octapharma, Hualan Bio are the leaders of the industry, and have been formed in the monopoly position in the industry.
According to this study, over the next five years the Albumin market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 6070 million by 2024, from US$ 4380 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albumin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Albumin market by product type, application, key manufacturers and key regions and countries.
This study considers the Albumin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Ventria (InVitria)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Albumin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Albumin market by identifying its various subsegments.
Focuses on the key global Albumin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Albumin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Albumin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
